Kidney Failure in the 21st Century
Since 1994, the number of US residents with chronic kidney disease stage 5 (kidney failure) has doubled; about half of these patients are currently undergoing dialysis. With new data continually emerging about the risks and benefits of each option for renal replacement therapy, it becomes increasingly important for primary care providers to become well-informed allies with their patients’ nephrology practitioners.
CONCLUSION
The decision to begin renal replacement therapy—whether a form of dialysis, or another management option—depends not on SCr or eGFR alone. Rather, a number of uremic manifestations, comorbidities, lifestyle factors, and other variables must be carefully weighed before the patient, the family, and the clinicians involved can decide on the management plan most likely to enhance the patient’s quality of life and extend survival.
